In the year 2000 the U.S. Food and Drug Administration (FDA) approved the drug mifepristone (also known as RU-486 or Mifeprex) as part of a regimen for chemically induced abortions. But on April 7, 2023—late on Good Friday—a federal judge in Texas issued a preliminary injunction that suspended the FDA’s approval of mifepristone, pending a trial on the merits of the case. The preliminary injunction was partially reversed on appeal, but the judge’s opinion in Alliance for Hippocratic Medicine v. FDA casts a spotlight on the damage that mifepristone has caused to women and their preborn children. Host Michael Pauley is joined by Adam Schwend of Susan B. Anthony Pro-Life America to discuss the implications of the Alliance for Hippocratic Medicine case, regarded by many legal experts as the most important abortion-related litigation since the Dobbs decision.

Subscribe to our PodCast